4.6 Article

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease

Journal

PLOS ONE
Volume 7, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0032912

Keywords

-

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)
  2. Universidade Federal de Ouro Preto (UFOP)
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  4. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Ask authors/readers for more resources

Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host interaction and/or target cell invasion, they differ in the molecules present on the surface. Thus, aspects related to the variability that the forms of T. cruzi interacts with host cells may lead to fundamental implications on the immune response against this parasite and, consequently, the clinical evolution of Chagas disease. We have shown that BT infected mice presented higher levels of parasitemia during all the acute phase of infection. Moreover, the infection with either MT or BT forms resulted in increased levels of total leukocytes, monocytes and lymphocytes, specifically later for MT and earlier for BT. The infection with BT forms presented earlier production of proinflammatory cytokine TNF-alpha and later of IFN-gamma by both T cells subpopulations. This event was accompanied by an early cardiac inflammation with an exacerbation of this process at the end of the acute phase. On the other hand, infection with MT forms result in an early production of IFN-gamma, with subsequent control in the production of this cytokine by IL-10, which provided to these animals an immunomodulatory profile in the end of the acute phase. These results are in agreement with what was found for cardiac inflammation where animals infected with MT forms showed intense cardiac inflammation later at infection, with a decrease in the same at the end of this phase. In summary, our findings emphasize the importance of taking into account the inoculums source of T. cruzi, since vectorial or transfusional routes of T. cruzi infection may trigger distinct parasite-host interactions during the acute phase that may influence relevant biological aspects of chronic Chagas disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Chemokines in Leishmaniasis: Map of cell movements highlights the landscape of infection and pathogenesis

Fernanda Fortes de Araujo, Matheus Fernandes Costa-Silva, Agnes Antonia Sampaio Pereira, Felipe Dutra Rego, Victoria Hellena Silva Pereira, Jaqueline Paulino de Souza, Luana Oliveira Borges Fernandes, Olindo Assis Martins-Filho, Celia Maria Ferreira Gontijo, Vanessa Peruhype-Magalhaes, Andrea Teixeira-Carvalho

Summary: Interactions between pathogens and host immune responses are critical for immunity and pathology against Leishmania parasites. Proinflammatory responses enhance immune control, while anti-inflammatory responses favor parasite proliferation. Chemokines play a key role in determining cellular composition at inflammatory sites.

CYTOKINE (2021)

Article Engineering, Multidisciplinary

Hierarchical median narrow band for level set segmentation of cervical cell nuclei

Alan M. Braga, Regis C. P. Marques, Fatima N. S. Medeiros, Jeova F. S. Rocha Neto, Andrea G. C. Bianchi, Claudia M. Carneiro, Daniela M. Ushizima

Summary: This paper introduces a novel hierarchical nuclei segmentation algorithm based on narrow band level set implementation, which achieved significant accuracy and Dice coefficient values in the segmentation of cervical cell images, and demonstrated high average accuracy in classification experiments. The results indicate the suitability of the algorithm for integration into decision support systems for cervical cell screening.

MEASUREMENT (2021)

Article Medicine, Research & Experimental

MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients

Carolina D'Avila-Mesquita, Ariel E. S. Couto, Ligia C. B. Campos, Tauana F. Vasconcelos, Jessyca Michelon-Barbosa, Carlos A. C. Corsi, Fabiola Mestriner, Bruno C. Petroski-Moraes, Maria J. Garbellini-Diab, Daniel M. S. Couto, Maria C. Jordani, Denise Ferro, Lourenco Sbragia, Edwaldo E. Joviliano, Paulo R. Evora, Rodrigo de Carvalho Santana, Olindo Assis Martins-Filho, Katarzyna Polonis, Mayra G. Menegueti, Mauricio S. Ribeiro, Maria Auxiliadora-Martins, Christiane Becari

Summary: The study revealed that plasma levels of MMP-2 and MMP-9 in COVID-19 patients were associated with clinical outcomes and mortality. MMP-9 levels in COVID-19 patients were influenced by comorbidities such as hypertension and obesity, while MMP-2 levels were affected by hypertension.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Parasitology

Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model

Livia Mendes Carvalho, Miria Rodrigues Gusmao, Ana Flavia Pereira Costa, Rory Cristiane Fortes de Brito, Rodrigo Dian de Oliveira Aguiar-Soares, Jamille Mirelle de Oliveira Cardoso, Alexandre Barbosa Reis, Claudia Martins Carneiro, Bruno Mendes Roatt

Summary: The immunochemotherapy using miltefosine along with LBSapMPL-vaccine showed promising results in controlling Leishmania infection and upregulating immunity, suggesting it as a potential alternative option for human and canine visceral leishmaniasis.

PARASITOLOGY (2022)

Article Multidisciplinary Sciences

Defining the early stages of intestinal colonisation by whipworms

Maria A. Duque-Correa, David Goulding, Faye H. Rodgers, Claire Cormie, Kate Rawlinson, J. Andrew Gillis, Allison J. Bancroft, Hayley M. Bennett, Magda Lotkowska, Adam J. Reid, Anneliese Speak, Paul Scott, Nicholas Redshaw, Catherine McCarthy, Cordelia Brandt, Catherine Sharpe, Caroline Ridley, Judit Gali Moya, Claudia M. Carneiro, Tobias Starborg, Kelly S. Hayes, Nancy Holroyd, Mandy Sanders, David J. Thornton, Richard K. Grencis, Matthew Berriman

Summary: Whipworms are large parasites causing chronic disease in humans and other mammals. Researchers have discovered how the larvae invade host epithelial cells, establishing infection by degrading mucus layers and creating tunnels. This interaction between the whipworm and the host triggers an immune response and tissue repair.

NATURE COMMUNICATIONS (2022)

Article Immunology

Successive Pandemic Waves with Different Virulent Strains and the Effects of Vaccination for SARS-CoV-2

Alcides Castro e Silva, Americo Tristao Bernardes, Eduardo Augusto Goncalves Barbosa, Igor Aparecido Santana das Chagas, Wesley Dattilo, Alexandre Barbosa Reis, Servio Pontes Ribeiro

Summary: This article studies a version of the SIR model that takes into account the spatial localization, movement, and social isolation probabilities of individuals. The effects of virus variants and vaccination rates on pandemic dynamics are discussed. The study shows that continuous waves of infections will occur unless global vaccination is implemented.

VACCINES (2022)

Article Multidisciplinary Sciences

Invariant surface glycoprotein 65 of Trypanosoma brucei is a complement C3 receptor

Olivia J. S. Macleod, Alexander D. Cook, Helena Webb, Mandy Crow, Roisin Burns, Maria Redpath, Stefanie Seisenberger, Camilla E. Trevor, Lori Peacock, Angela Schwede, Nicola Kimblin, Amanda F. Francisco, Julia Pepperl, Steve Rust, Paul Voorheis, Wendy Gibson, Martin C. Taylor, Matthew K. Higgins, Mark Carrington

Summary: The study reveals that ISG65 of T. brucei functions as a receptor for complement component 3 and plays a role in reducing trypanosome susceptibility to C3-mediated clearance. This finding provides important insights into the interaction between trypanosomes and the innate immune system.

NATURE COMMUNICATIONS (2022)

Article Infectious Diseases

Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure

Amanda Fortes Francisco, Ursula Saade, Shiromani Jayawardhana, Hans Pottel, Ivan Scandale, Eric Chatelain, Peter Liehl, John M. Kelly, Maan Zrein

Summary: This study evaluated serological procedures for the diagnosis of T. cruzi infections and confirmation of parasitological cure using an experimental mouse model. The researchers identified a set of antigens that provide a rapid and accurate read-out of both acute and chronic T. cruzi infection. They also discovered specific antibody responses that can be correlated with parasite reduction or persistent infection. These findings could be used to develop diagnostic techniques and biomarkers for monitoring the efficacy of anti-T. cruzi drug treatment in a clinical setting.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Article Chemistry, Medicinal

Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection

Taisuke Tawaraishi, Atsuko Ochida, Yuichiro Akao, Sachiko Itono, Masahiro Kamaura, Thamina Akther, Mitsuyuki Shimada, Stacie Canan, Sanjoy Chowdhury, Yafeng Cao, Kevin Condroski, Ola Engkvist, Amanda Francisco, Sunil Ghosh, Rina Kaki, John M. Kelly, Chiaki Kimura, Thierry Kogej, Kazuya Nagaoka, Akira Naito, Garry Pairaudeau, Constantin Radu, Ieuan Roberts, David Shum, Nao-aki Watanabe, Huanxu Xie, Shuji Yonezawa, Osamu Yoshida, Ryu Yoshida, Charles Mowbray, Benjamin Perry

Summary: Probing multiple proprietary pharmaceutical libraries in parallel through virtual screening led to the rapid expansion of structure-activity relationship (SAR) around hit compounds with moderate efficacy against Trypanosoma cruzi. The SAR was further developed through a potency-improving scaffold hop and design guided by phenotypic virtual screening, resulting in the identification of two promising hit compounds 54 and 85. Compound 85 showed a significant reduction in parasitemia in an in vivo model, confirming its potential as an anti-trypanosome treatment.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Immunology

The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection

Fernando Augusto Siqueira Mathias, Thais Lopes Valentim Di Paschoale Ostolin, Levi Eduardo Soares Reis, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Rodrigo Dian de Oliveira Aguiar Soares, Bruno Mendes Roatt, Paula Melo de Abreu Vieira, Alexandre Barbosa Reis

Summary: This study evaluated the effect and optimal dose of adjuvant systems for a vaccine candidate against Leishmania (Viannia) braziliensis. The combination of saponin and monophosphoryl lipid A (SM) as an adjuvant system increased the production of TNF and IFN-gamma, leading to the generation of central and effector memory CD4(+) T cells. Therefore, using an adjuvant system can enhance the innate immune response and has the potential for future vaccine development.

VACCINES (2023)

Article Chemistry, Medicinal

Bis-6-amidino-benzothiazole Derivative that Cures Experimental Stage 1 African Trypanosomiasis with a Single Dose

Livio Racane, Lucija Pticek, Sanja Kostrun, Silvana Raic-Malic, Martin Craig Taylor, Michael Delves, Sam Alsford, Francisco Olmo, Amanda Fortes Francisco, John M. Kelly

Summary: We designed and synthesized a series of symmetric benzothiazole derivatives and evaluated their efficacy against Trypanosoma brucei and Plasmodium falciparum. One compound showed high selectivity and trypanocidal activity, curing mice infected with trypanosomiasis. It also exhibited activity against the malaria parasite.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections

Srinivasa P. S. Rao, Matthew K. Gould, Jonas Noeske, Manuel Saldivia, Rajiv S. Jumani, Pearly S. Ng, Olivier Rene, Yen-Liang Chen, Marcel Kaiser, Ryan Ritchie, Amanda Fortes Francisco, Nila Johnson, Debjani Patra, Harry Cheung, Colin Deniston, Andreas D. Schenk, Wilian A. Cortopassi, Remo S. Schmidt, Natalie Wiedemar, Bryanna Thomas, Rima Palkar, Nahdiyah A. Ghafar, Vanessa Manoharan, Catherine Luu, Jonathan E. Gable, Kah Fei Wan, Elmarie Myburgh, Jeremy C. Mottram, Whitney Barnes, John Walker, Charles Wartchow, Natasha Aziz, Colin Osborne, Juergen Wagner, Christopher Sarko, John M. Kelly, Ujjini H. Manjunatha, Pascal Maeser, Jan Jiricek, Suresh B. Lakshminarayana, Michael P. Barrett, Thierry T. Diagana

Summary: Millions of people in Latin America and sub-Saharan Africa are at risk of trypanosomatid infections. Researchers have identified a class of cyanotriazoles (CTs) that have potent trypanocidal activity and can potentially be used for the treatment of Chagas disease and human African trypanosomiasis. These CT compounds act by selectively and irreversibly inhibiting trypanosomal topoisomerase II and stabilizing DNA:enzyme cleavage complexes.

SCIENCE (2023)

Article Microbiology

Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease

Amanda Fortes Francisco, Giovane R. Sousa, Mhairi Vaughan, Harry Langston, Archie Khan, Shiromani Jayawardhana, Martin C. Taylor, Michael D. Lewis, John M. Kelly

Summary: This study demonstrates the potential of the C3H/HeN:JR host:parasite combination as an experimental model for Chronic Chagas cardiomyopathy (CCC). The model exhibited cardiac abnormalities and inflammation, and could be used for screening new compounds and drugs to prevent or alleviate CCC development.

PATHOGENS (2023)

Article Chemistry, Medicinal

Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection

Chee Wei Ang, Brendon M. Lee, Colin J. Jackson, Yuehong Wang, Scott G. Franzblau, Amanda F. Francisco, John M. Kelly, Paul Bernhardt, Lendl Tan, Nicholas P. West, Melissa L. Sykes, Alexandra O. Hinton, Raghu Bolisetti, Vicky M. Avery, Matthew A. Cooper, Mark A. T. Blaskovich

Summary: Tuberculosis and parasitic infections pose a significant threat to public health and economic growth worldwide. This study explores a new subclass of bicyclic nitroimidazole compounds and their potential as treatments for tuberculosis and Chagas disease, demonstrating promising results in vitro and in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Letter Parasitology

Heading back into the perfect storm: increasing risks for disease emergence in Brazil?

Servio Pontes Ribeiro, Mariana Moncassin Vale, Jose Alexandre Felizola Diniz-Filho, Geraldo Wilson Fernandes, Alexandre Barbosa Reis, Carlos Eduardo de Viveiros Grelle

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2022)

No Data Available